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Diabetes causes about 5% of all the deaths 
happening globally each year. India is projected to 
experience the greatest global increase in Type 2 
diabetes mellitus (T2DM) by 2025.  In rural settings 
within India, the prevalence of diabetes is relatively low 
at around 2.7%  but rises dramatically in urban 
communities throughout India, and even more so 
amongst South Asian immigrants to the Western world. 
T2DM is a genetically heterogeneous, polygenic 
disease with a complex inheritance pattern and is 
caused by genetic predisposition and environmental 
factors. Asian Indians are more prone to develop 
T2DM and metabolic syndrome compared to 
Europeans, largely because of increased tendency to 
develop central obesity, higher prevalence of insulin 
resistance, hyperinsulinemia and dyslipidemia. Chronic 
hyperglycemia is often associated with essential 
hypertension, obesity and dyslipidemia in a complex 
metabolic syndrome leading to severe vascular 
complications including retinopathy, neuropathy, 
nephropathy and increased risk of cardiovascular 
disorders. Ethnic variations and environmental factors 
contribute a lot in various manifestations of the disease. 
The ethnic diversity in the Indian sub-continent 
essentially offers the genetic architecture of global 
population. There is a need to study and understand 
the genetic susceptibility for type 2 diabetes mellitus, 
its associated traits and its various complications 
including renal, neurological and opthalmological 
complications. India is emerging as most favoured 
destination for medical tourism. To establish India in 
leading position in the global diabetes treatment a 
holistic approach to the management of diabetes is a 
must. To look at the advances in diabetes treatment in 
Ayurveda, Allopathy, Unani-Tibb, siddha and 
homeopathy KLES Dr. Prabhakar Kore Hospital & 
Medical Research Centre, Belgaum organized a 
national seminar on diabetes. There were 400 
participants from different institutes of India.  
Vijay Panikar (Lilavati Hospital & Research Centre, 
Mumbai) in his inaugural address spoke on New 
Horizons of OHA: Which, When and Why? He shared 
his experience and results as well as the United 
Kingdom Prospective Diabetes Study (UKPDS) 
mandate to treat type 2 diabetes which includes 
aggressive efforts to lower blood glucose levels as 
close to normal as possible. Overall Systolic blood 
pressure, Waist to hip ratio, Serum Triglycerides and 
Fasting blood sugar are predictors of Metabolic 
syndrome in diabetic and non-diabetic males, 
irrespective of age and family history. HDL cholesterol, 
Waist to hip ratio, Systolic blood pressure and Serum 
Triglycerides are predictors of Metabolic syndrome in 
Diabetic and non-diabetic female irrespective of age 
and family history. He shared his experience in using a 
combination of pioglitazone and metformin, 
improvement of β-cell function and increased insulin 
sensitivity etc. Ashok Kumar Das, (JIPMER, 
Puducherry) in his plenary talk presented on Metformin 
– 53: Still batting, not out, spoke on history of 
metformin usage in India compared with that in USA, 
and its usage in treating cancer. Stressed health 
professionals need to develop the comfort and 
competence to address the concerns of their clients at 
a level appropriate to themselves, their clients and the 
clinical situation; with the option of referral to higher 
levels of management.  He also briefed the ICMR, 
WHO initiates in Diabetes research as well as 
awareness programme initiatives. H.B. Chandalia 
(Executive Patron, Research Society for Study of 
Diabetes in India [RSSDI], Lady Ratan Tata Medical & 
Research Centre, Mumbai) in his keynote address 
spoke on Glycated Haemoglobin (HbA1C). Vascular 
complications are the leading cause of morbidity and 
mortality in type 2 diabetes. Cardiovascular disease is 
significantly more common in patients with type 2 
diabetes than in non-diabetics, and accounts for more 
than two-thirds of deaths associated with the condition. 
Many physicians believe that hyperglycaemia is 
responsible, at least in part, for this additional risk. The 
benefit of improved glycaemic control on micro-
vascular complications is well established and recent 
trials have attempted to clarify the role of glycaemic 
control on macro-vascular outcomes.  Vijay 
Viswanathan (MV Hospital for Diabetes & Diabetes 
Research Centre, Chennai) Spoke on Diabetic 
Nephropathy and Kidney failure in Diabetes: Are genes 
completely responsible? He highlighted type 2 diabetes 
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and diabetic kidney disease as a new global pandemic. 
There is a need to alert governments and health 
organizations, as well as providers, physicians, and 
patients to the increasing health and socioeconomic 
problems due to diabetic kidney disease and its 
sequelae: end stage kidney disease requiring dialysis 
and cardiovascular death. Anil Bansali (PGI, 
Chandigarh) spoke on Stem cell therapy in diabetes. 
Embryonic and adult stem cells have been suggested 
as attractive sources for generation of new 
differentiated cells.  The use of stem cells in 
regenerative medicine holds great promise for the cure 
of many diseases, including type 1 diabetes mellitus 
(T1DM). Any potential stem-cell-based cure for T1DM 
should address the need for β-cell replacement, as well 
as control of the autoimmune response to cells which 
express insulin.  He discussed on current protocols 
followed in obtaining cells which express insulin from 
different progenitor sources and highlighted the main 
pathways and genes involved, as well as the different 
approaches for the modulation of the immune response 
in patients with T1DM. Jayanthi Ramesh (Osmania 
Medical College and Sai Institute of Endocrinology, 
Hyderabad) spoke on Current concepts of diabetes in 
gynaecology and Obstetrics. Screening for gestational 
diabetes mellitus (GDM) provides an opportunity of 
pregnancy outcome improvement. Both hypertension 
and vascular disease have been examined as 
conditions that may be predicted by GDM. Obesity and 
insulin resistance are central attributes of both GDM 
and the metabolic syndrome. These characteristics and 
dyslipidemia are associated with endothelial 
dysfunction, oxidative stress, and over expression of 
inflammatory responses, all of which contribute to 
vascular disease. These associations have significant 
public health ramifications because of the current 
epidemic of obesity, affecting individuals of all age-
groups.  Shaila Bhattacharya, Manipal Hospital, 
Bangalore, spoke on clinical management of diabetes 
in toddlers.  Insulin pump therapy has, within the last 
10 years, emerged as an increasingly popular modality 
of treatment to achieve intensive glycemic targets in 
type 1 diabetes (T1D). The evidence for the benefits of 
pump therapy has now been demonstrated in very 
young children. Arpan Bhattacharya, Manipal Hospital, 
Bangalore, spoke on use of insulin analogues in clinical 
practices. Insulin analogues are genetically engineered, 
state of the art, modified or designer insulin’s that have 
changed insulin treatment and improved glycemic 
control. Several clinical studies have shown that rapid 
acting analogues under various clinical situations 
provide superior glycemic control with more 
convenience and flexibility making them a patient 
friendly option. G. R. Chandak (CCMB, Hyderabad) 
spoke on genetic basis and gene environment 
interaction in type 2 diabetes in Indians: Mendelian 
randomization as an approach. More recent reports 
from various parts of India showed further increases in 
diabetes prevalence in urban areas.  Moreover, the 
prevalence of diabetes is also found to be increasing 
rapidly in rural areas, as a result of the recent 
socioeconomic transitions.  
G. R. Sridhar (President, RSSDI, 
Vishakapattanam) spoke on translating science into 
action in diabetes. A systematic review of the clinical 
database created at his centre at Vishakapattanam, its 
entry, Analysis of data from electronic large medical 
records, trend analysis etc. Younger the onset of 
diabetes, longer would be the period for potential 
vascular complications; in general women have a 
poorer quality of care, quality of life and wellbeing with 
diabetes, contributing to both the burden of disease as 
well as possible contribution of insulin resistance to the 
next generation. K.R. Suresh (Jain Institute of Vascular 
Science, Mahaveer Jain Hospital, Bangalore) spoke on 
surgical interventions for functional limb salvage in 
diabetic foot. Metabolic interventions to control 
progression of diabetic foot problems, Glycemic control 
at various forms and stages of diabetic foot problems, 
Class I to class IV surgical interventions, Surgery in 
charcots foot, Podiatric/ Orthopedic interventions 
external fixaters to surgical procedure, Tissue 
coverage for non healing ulcers etc. Diabetes is due to 
strong genetic factors coupled with urbanization and 
lifestyle changes, many of the adverse environmental 
factors are modifiable. Prevention of Type 2 diabetes 
will require measures to promote physical activity and 
stress reduction measures in the built environment they 
live in, and to reduce obesity in adults and children. 
To encourage the young diabetologists the 
organizing committee organized a 5 selected podium 
presentations and 10 poster presentations. Best 
podium presenter awarded with gold medal from 
National Diabetes Foundation and best poster 
presenters received awards from present RSSDI 
president. In the panel discussion the members 
expressed concern as per WHO diabetes deaths are 
likely to increase by more than 50% in the next 10 
years without urgent action. There is a need to improve 
health through stimulating and supporting the adoption 
of effective measures for the surveillance, prevention 
and control of diabetes and its complications, 
particularly in low- and middle-income vulnerable 
populations. The panel members urged health care 
professionals as well as young student participants to 
initiate diabetes awareness programs and aggressive 
control measures towards prevention and control of 
diabetes. 
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